title: Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia?
authors.forename: Rafael
authors.initials: R
authors.lastname: Penadés
authors.forename: Rosa
authors.initials: R
authors.lastname: Catalán
authors.forename: Núria
authors.initials: N
authors.lastname: Pujol
authors.forename: Olga
authors.initials: O
authors.lastname: Puig
authors.forename: Joana
authors.initials: J
authors.lastname: Guarch
authors.forename: Guillem
authors.initials: G
authors.lastname: Masana
authors.forename: Víctor
authors.initials: V
authors.lastname: Navarro
authors.forename: Cristóbal
authors.initials: C
authors.lastname: Gastó
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000523:psychology*; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010352:Patient Dropouts / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000628:therapy*; D012565:Schizophrenic Psychology
chemical_list: D014150:Antipsychotic Agents